Davis, CA, United States of America

L Edward Clemens

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Cymabay Therapeutics, Inc., Metabolex, Inc.. Active years: 2009-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: L Edward Clemens. Retrieved from https://idiyas.com/inventor/l-edward-clemens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 57.1


 

Average Co-Inventor Count = 12.0

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovative Thinker L Edward Clemens and His Contributions to Diabetes Treatment**

Introduction

L Edward Clemens is a notable inventor based in Davis, California, recognized for his significant contributions to the field of diabetes and metabolic disorders. With an impressive portfolio of seven patents, Clemens has dedicated his career to innovating solutions for conditions associated with poor glycemic control.

Latest Patents

Clemens' latest patents focus on heterocyclic receptor agonists aimed at the treatment of diabetes and related metabolic disorders. These compounds and methods provide innovative approaches to managing Type II diabetes, demonstrating oral activity that may enhance patient compliance and treatment efficacy.

Career Highlights

Throughout his career, Clemens has been associated with reputable companies such as Cymabay Therapeutics, Inc. and Metabolex, Inc. His contributions have played a crucial role in the development of therapeutic options that address significant health challenges faced by those suffering from diabetes.

Collaborations

Clemens has collaborated with distinguished professionals in his field, including colleagues like Xin Chen and Peng Cheng. Together, they have worked on advancing research that underpins the innovative treatments originating from his patents.

Conclusion

L Edward Clemens continues to be an influential inventor whose work has the potential to change the landscape of diabetes treatment. His commitment to innovation not only highlights his expertise but also underscores the importance of dedicated research in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…